Tekmira Inc. shares slumped following to the news of stopping the new enrollments of Ebola Patients in Africa. The firm says being at a Statistical Endpoint the enrollment is halted. The decision was made due to not having significant progress in Ebola treatments. View the full release here.
News: Tekmira halts Ebola Enrollment in Africa $TKMR Read More »
In April 2015, Eu sent Google Inc., a lengthy charge sheet demanding changes in Shopping Rankings. The claims relates to the underlying processes of shopping comparisons. These comparison processes may lead the firm to Antitrust policy violation. Google has a few weeks and on oral hearing to respond. View the full release here.
News: EU Claims on Google $GOOG Read More »
Red Hat, Inc., the world’s leader of open source solutions, has announce dits furst quarter results of Fy-2015-16. The results shows revenues rise by 14% to $481 Million whereas EPS was reported $0.26 up from $0.20 YoY. As per Financials year-over-year Subscription revenue for the quarter was $425 million, up 14% GAAP operating income for
Earnings: Redhat Revenues Up $RHT Read More »
Provectus Biopharmaceuticals., has announced the equity offering of Common stock and warrants. The net proceeds would be used in clinical development, working capital and general corporate purposes. Offer is yet to be approved by the authorities. View the full release here.
News: Provectus Equity Offering $PVCT Read More »
Sandonz has launched the generic substitute of Copaxone naming Glatopa the first FDA-approved, substitute generic version of Copaxone® 20mg. The drug is used as a treatment for relapsing forms of multiple sclerosis. Glatopa, developed in collaboration with Momenta and produced entirely in the US. View the full release here.
News: Sandoz Launches Glatopa Copy of Copaxone $NVS Read More »
